Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer surface protein C (OspC) is a 22-23 kDa dimeric lipoprotein located on the outer membrane of Borrelia burgdorferi, the primary causative agent of Lyme disease [5, 9]. It plays a fundamental role in the pathogen's life cycle, being essential for the migration of spirochetes from the tick midgut to the salivary glands and their subsequent transmission into the mammalian host [6, 15]. Once inside the host, OspC facilitates early infection and dissemination by binding to host factors such as plasminogen and complement component C4b, thereby aiding in immune evasion and tissue colonization [3, 5, 17]. As a highly immunogenic protein, OspC is a major target for diagnostic assays, particularly for detecting early-stage Lyme disease through IgM and IgG antibody responses [18]. It is also a prominent candidate for vaccine development, as antibodies against OspC exhibit potent borreliacidal activity [6, 13]. However, the significant antigenic variation across different Borrelia strains (with over 30 known OspC types) complicates the development of a universal vaccine [7, 10]. Current research focuses on polyvalent or chimeric vaccine strategies to overcome this diversity and provide broad-spectrum protection [7, 13].
Induction of borreliacidal antibodies that neutralize spirochetes and prevent tick-to-host transmission and early mammalian infection.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer surface protein C (OspC) (OspC).